Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom
**Background:** Gastro-oesophageal reflux disease (GORD) is a common condition associated with heartburn and regurgitation. Standard of care for GORD patients in the UK involves initial treatment with proton pump inhibitors (PPIs) and laparoscopic antireflux surgery in patients unwilling to continue...
Saved in:
Main Authors: | Sam Harper, Lukasz Grodzicki, Stuart Mealing, Elizabeth Gemmill, Paul Goldsmith, Ahmed Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2024-01-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.90924 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term risk factors for developing Barrett’s oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study
by: John F Dillon, et al.
Published: (2024-06-01) -
Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01) -
New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2014-11-01) -
The refractory form of gastroesophageal reflux disease: clinical and endoscopical, functional and morphofunctional criteria
by: M. A. Osadchuk, et al.
Published: (2011-03-01) -
The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma
by: O. A. Storonova, et al.
Published: (2024-08-01)